E-LIB Suche - Ergebnisse für: Fay, Brittany

1

DON in pediatric cerebral malaria, a phase I/IIA dose-escal..:

Nampota-Nkomba, Nginache ; Nyirenda, Osward M. ; Mallewa, Jane...
Trials. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Blazing a trail for the clinical use of rapamycin as a gero..:

Konopka, Adam R. ; Lamming, Dudley W. ; Grasso, Brittany A....
GeroScience. , 2023

Link: https://doi.org/10.1007/..

3

442-K A CAR T cell approach for treating B cell lineage can..:

Shenyu Zhang ; Zhengyu Ma ; Brittany Fay
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

4

Impact of worst pain severity and morning fatigue profiles ..:

Bouvron, Brittany ; Mackin, Lynda ; Kober, Kord M....
Supportive Care in Cancer. 30 (2022) 12 - p. 9929-9944 , 2022

Link: https://doi.org/10.1007/..

5

Ruxolitinib Cream Ameliorates Itch and Inflammation in Prec..:

Scuron, Monika ; Fay, Brittany ; Connell, Andrew..
Journal of Allergy and Clinical Immunology. 147 (2021) 2 - p. AB33 , 2021

Link: https://doi.org/10.1016/..

6

The PI3Kδ inhibitor parsaclisib ameliorates pathology and r..:

Scuron, Monika D. ; Fay, Brittany L. ; Connell, Andrew J...
International Immunopharmacology. 98 (2021) - p. 107904 , 2021

Link: https://doi.org/10.1016/..

7

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm..:

Huarte, Eduardo ; Peel, Michael T. ; Verbist, Katherine...
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

8

Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflamm..:

Scuron, Monika D. ; Fay, Brittany L. ; Connell, Andrew J...
Frontiers in Immunology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

9

Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflamm..:

Monika D. Scuron ; Brittany L. Fay ; Andrew J. Connell..
https://www.frontiersin.org/articles/10.3389/fimmu.2020.620098/full. , 2021

Link: https://doi.org/10.3389/..

10

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm..:

Eduardo Huarte ; Michael T. Peel ; Katherine Verbist...
https://www.frontiersin.org/articles/10.3389/fphar.2021.650295/full. , 2021

Link: https://doi.org/10.3389/..

11

image1_Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokin..:

Eduardo Huarte (114248) ; Michael T. Peel (10699236) ; Katherine Verbist (10699239)...
https://figshare.com/articles/figure/image1_Ruxolitinib_a_JAK1_2_Inhibitor_Ameliorates_Cytokine_Storm_in_Experimental_Models_of_Hyperinflammation_Syndrome_jpeg/14482902. , 2021

Link: https://doi.org/10.3389/..

12

image1_Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokin..:

Eduardo Huarte ; Michael T. Peel ; Katherine Verbist...
doi:10.3389/fphar.2021.650295.s001. , 2021

Link: https://doi.org/10.3389/..

13

Preclinical characterization of itacitinib (INCB039110), a ..:

Covington, Maryanne ; He, Xin ; Scuron, Monika...
European Journal of Pharmacology. 885 (2020) - p. 173505 , 2020

Link: https://doi.org/10.1016/..

14

One thousand plant transcriptomes and the phylogenomics of ..:

Leebens-Mack, James H ; Barker, Michael S ; Carpenter, Eric J...
doi:10.17863/CAM.58915. , 2020

Link: https://doi.org/10.17863..

15

Oral hygiene effects verbal and nonverbal displays of confi..:

Taylor, Paul ; Banks, Fay ; Jolley, Daniel...
https://researchportal.bath.ac.uk/en/publications/42b4ce16-6d5b-427b-bea9-a40cdbe731cf. , 2020

Link: https://researchportal.b..